Severe Refractory Immune Thrombocytopenia Successfully Treated with High-Dose Pulse Cyclophosphamide and Eltrombopag (scientific article)

High dose cyclophosphamide, BCNU, and VP-16 (CBV) as a conditioning regimen for allogeneic bone marrow transplantation for patients with acute leukemia

Q68933906

Immunoablative high-dose cyclophosphamide without stem-cell rescue for refractory, severe autoimmune disease

Q77732658

Long-term salvage therapy with cyclosporin A in refractory idiopathic thrombocytopenic purpura

Q33340938

High-dose cyclophosphamide with autologous lymphocyte-depleted peripheral blood stem cell (PBSC) support for treatment of refractory chronic autoimmune thrombocytopenia

Q33344858

Monoclonal IgG can ameliorate immune thrombocytopenia in a murine model of ITP: an alternative to IVIG.

Q33345890

Management of adult patients with persistent idiopathic thrombocytopenic purpura following splenectomy: a systematic review

Q33358643

Long-term outcomes in adults with chronic ITP after splenectomy failure

Q33360520

Platelet-associated CD154 in immune thrombocytopenic purpura

Q33361212

How I treat idiopathic thrombocytopenic purpura (ITP).

Q33366679

Immune thrombocytopenic purpura--the changing therapeutic landscape

Q33373029

Multiagent induction and maintenance therapy for patients with refractory immune thrombocytopenic purpura (ITP).

Q33376235

Idiopathic thrombocytopenic purpura: current concepts in pathophysiology and management

Q33378392

The ITP syndrome: pathogenic and clinical diversity

Q33384235

Combination immunosuppressant therapy for patients with chronic refractory immune thrombocytopenic purpura

Q33386987

Amelioration of murine immune thrombocytopenia by CD44 antibodies: a potential therapy for ITP?

Q33392654

The efficacy and safety of romiplostim in adult patients with chronic immune thrombocytopenia

Q33407279

Immune thrombocytopenia: recent progress in pathophysiology and treatment

Q33413896

Antibody against megakaryocytes in idiopathic thrombocytopenic purpura

Q33472296

Pulse cyclophosphamide therapy for refractory autoimmune thrombocytopenic purpura.

Q33490097

Response of resistant idiopathic thrombocytopenic purpura to pulsed high-dose dexamethasone therapy

Q33492656

Autologous peripheral blood stem cell transplantation in a patient with chronic autoimmune thrombocytopenia.

Q33500729

High-dose cyclophosphamide for severe aplastic anemia: long-term follow-up

Q33747331

High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease.

Q33806054

Haemopoietic stem cell transplantation in the treatment of severe autoimmune diseases 2000.

Q43051745

P275

Creative Commons Attribution 3.0 Unported

copyrighted

main subject

thrombocytopenia

Q585285

P304

page(s)

583451

P577

publication date

2015-06-09

P1433

published in

Case reports in hematology

Q27724373

P1476

title

Severe Refractory Immune Thrombocytopenia Successfully Treated with High-Dose Pulse Cyclophosphamide and Eltrombopag

P478

volume

2015

Reverse relations

cites work (P2860)

Q90601285	A Case of Primary Refractory Immune Thrombocytopenia: Challenges in Choice of Therapies
Q33442065	A practical guide to the use of eltrombopag in children with chronic immune thrombocytopenia
Q64120714	Computational Molecular Phenotypic Analysis of PTPN22 (W620R), IL6R (D358A), and TYK2 (P1104A) Gene Mutations of Rheumatoid Arthritis
Q57818187	Eltrombopag-based combination treatment for immune thrombocytopenia
Q33430522	New synergistic efficacy of combination of romiplostim and steroid in refractory immune thrombocytopenia patients

Warning: Trying to access array offset on value of type null in /home/httpd/vhosts/renenyffenegger.ch/opendata.renenyffenegger.ch/Wikimedia/Wikidata/entity/main.php on line 1120 Warning: Trying to access array offset on value of type null in /home/httpd/vhosts/renenyffenegger.ch/opendata.renenyffenegger.ch/Wikimedia/Wikidata/entity/main.php on line 1120